Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast

Adjuvant antioestrogen therapy with tamoxifen is recommended for all women following breast-conserving surgery for ductal carcinoma in situ (DCIS) to reduce local recurrence, despite 50% of lesions being oestrogen receptor (OR) negative. We have investigated the response to hormone manipulation in D...

Descripción completa

Detalles Bibliográficos
Autores principales: Boland, G P, Mckeown, A, Chan, K C, Prasad, R, Knox, W F, Bundred, N J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Molecular and Cellular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394241/
https://www.ncbi.nlm.nih.gov/pubmed/12865917
http://dx.doi.org/10.1038/sj.bjc.6601013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394241/
https://www.ncbi.nlm.nih.gov/pubmed/12865917
http://dx.doi.org/10.1038/sj.bjc.6601013

Ejemplares similares